Global Interventional Cardiology and Peripheral Vascular Devices Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02254733

Publication Date:

February 27, 2025

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Interventional Cardiology and Peripheral Vascular Devices market size is predicted to grow from US$ 6691 million in 2025 to US$ 7821 million in 2031; it is expected to grow at a CAGR of 2.6% from 2025 to 2031.
Peripheral vascular devices are a kind of devices which is used in the treatment of diseased blood vessels outside of the brain and heart. Peripheral vascular devices include peripheral vascular stents, PTA balloon catheter, embolic protection device, aortic stent graft and surgical artificial transplant.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淚nterventional Cardiology and Peripheral Vascular Devices Industry Forecast鈥� looks at past sales and reviews total world Interventional Cardiology and Peripheral Vascular Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Interventional Cardiology and Peripheral Vascular Devices sales for 2025 through 2031. With Interventional Cardiology and Peripheral Vascular Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Cardiology and Peripheral Vascular Devices industry.
This Insight Report provides a comprehensive analysis of the global Interventional Cardiology and Peripheral Vascular Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Interventional Cardiology and Peripheral Vascular Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Interventional Cardiology and Peripheral Vascular Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Cardiology and Peripheral Vascular Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Cardiology and Peripheral Vascular Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Cardiology and Peripheral Vascular Devices market by product type, application, key players and key regions and countries.
Segmentation by Type:
Angioplasty Balloons
Catheters
Angioplasty Stents
Other
Segmentation by Application:
Hospitals
Clinics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Angiomed GmbH
Abbott
Boston Scientific
Aesculap AG
Terumo Corporation
ENDOLOGIX
Cook Medical
Bolton Medical
Jotec GmbH
Lepu
Microport
Bioteq

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Cardiology and Peripheral Vascular Devices Market Size (2020-2031)
2.1.2 Interventional Cardiology and Peripheral Vascular Devices Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Interventional Cardiology and Peripheral Vascular Devices by Country/Region (2020, 2024 & 2031)
2.2 Interventional Cardiology and Peripheral Vascular Devices Segment by Type
2.2.1 Angioplasty Balloons
2.2.2 Catheters
2.2.3 Angioplasty Stents
2.2.4 Other
2.3 Interventional Cardiology and Peripheral Vascular Devices Market Size by Type
2.3.1 Interventional Cardiology and Peripheral Vascular Devices Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Interventional Cardiology and Peripheral Vascular Devices Market Size Market Share by Type (2020-2025)
2.4 Interventional Cardiology and Peripheral Vascular Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Interventional Cardiology and Peripheral Vascular Devices Market Size by Application
2.5.1 Interventional Cardiology and Peripheral Vascular Devices Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Interventional Cardiology and Peripheral Vascular Devices Market Size Market Share by Application (2020-2025)
3 Interventional Cardiology and Peripheral Vascular Devices Market Size by Player
3.1 Interventional Cardiology and Peripheral Vascular Devices Market Size Market Share by Player
3.1.1 Global Interventional Cardiology and Peripheral Vascular Devices Revenue by Player (2020-2025)
3.1.2 Global Interventional Cardiology and Peripheral Vascular Devices Revenue Market Share by Player (2020-2025)
3.2 Global Interventional Cardiology and Peripheral Vascular Devices Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Interventional Cardiology and Peripheral Vascular Devices by Region
4.1 Interventional Cardiology and Peripheral Vascular Devices Market Size by Region (2020-2025)
4.2 Global Interventional Cardiology and Peripheral Vascular Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Interventional Cardiology and Peripheral Vascular Devices Market Size Growth (2020-2025)
4.4 APAC Interventional Cardiology and Peripheral Vascular Devices Market Size Growth (2020-2025)
4.5 Europe Interventional Cardiology and Peripheral Vascular Devices Market Size Growth (2020-2025)
4.6 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices Market Size Growth (2020-2025)
5 Americas
5.1 Americas Interventional Cardiology and Peripheral Vascular Devices Market Size by Country (2020-2025)
5.2 Americas Interventional Cardiology and Peripheral Vascular Devices Market Size by Type (2020-2025)
5.3 Americas Interventional Cardiology and Peripheral Vascular Devices Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Cardiology and Peripheral Vascular Devices Market Size by Region (2020-2025)
6.2 APAC Interventional Cardiology and Peripheral Vascular Devices Market Size by Type (2020-2025)
6.3 APAC Interventional Cardiology and Peripheral Vascular Devices Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Interventional Cardiology and Peripheral Vascular Devices Market Size by Country (2020-2025)
7.2 Europe Interventional Cardiology and Peripheral Vascular Devices Market Size by Type (2020-2025)
7.3 Europe Interventional Cardiology and Peripheral Vascular Devices Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices by Region (2020-2025)
8.2 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices Market Size by Type (2020-2025)
8.3 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Interventional Cardiology and Peripheral Vascular Devices Market Forecast
10.1 Global Interventional Cardiology and Peripheral Vascular Devices Forecast by Region (2026-2031)
10.1.1 Global Interventional Cardiology and Peripheral Vascular Devices Forecast by Region (2026-2031)
10.1.2 Americas Interventional Cardiology and Peripheral Vascular Devices Forecast
10.1.3 APAC Interventional Cardiology and Peripheral Vascular Devices Forecast
10.1.4 Europe Interventional Cardiology and Peripheral Vascular Devices Forecast
10.1.5 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices Forecast
10.2 Americas Interventional Cardiology and Peripheral Vascular Devices Forecast by Country (2026-2031)
10.2.1 United States Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.2.2 Canada Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.2.3 Mexico Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.2.4 Brazil Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.3 APAC Interventional Cardiology and Peripheral Vascular Devices Forecast by Region (2026-2031)
10.3.1 China Interventional Cardiology and Peripheral Vascular Devices Market Forecast
10.3.2 Japan Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.3.3 Korea Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.3.4 Southeast Asia Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.3.5 India Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.3.6 Australia Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.4 Europe Interventional Cardiology and Peripheral Vascular Devices Forecast by Country (2026-2031)
10.4.1 Germany Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.4.2 France Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.4.3 UK Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.4.4 Italy Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.4.5 Russia Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.5 Middle East & Africa Interventional Cardiology and Peripheral Vascular Devices Forecast by Region (2026-2031)
10.5.1 Egypt Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.5.2 South Africa Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.5.3 Israel Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.5.4 Turkey Market Interventional Cardiology and Peripheral Vascular Devices Forecast
10.6 Global Interventional Cardiology and Peripheral Vascular Devices Forecast by Type (2026-2031)
10.7 Global Interventional Cardiology and Peripheral Vascular Devices Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Interventional Cardiology and Peripheral Vascular Devices Forecast
11 Key Players Analysis
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.1.3 Medtronic Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 Angiomed GmbH
11.2.1 Angiomed GmbH Company Information
11.2.2 Angiomed GmbH Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.2.3 Angiomed GmbH Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Angiomed GmbH Main Business Overview
11.2.5 Angiomed GmbH Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.3.3 Abbott Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Company Information
11.4.2 Boston Scientific Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.4.3 Boston Scientific Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Boston Scientific Main Business Overview
11.4.5 Boston Scientific Latest Developments
11.5 Aesculap AG
11.5.1 Aesculap AG Company Information
11.5.2 Aesculap AG Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.5.3 Aesculap AG Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Aesculap AG Main Business Overview
11.5.5 Aesculap AG Latest Developments
11.6 Terumo Corporation
11.6.1 Terumo Corporation Company Information
11.6.2 Terumo Corporation Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.6.3 Terumo Corporation Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Terumo Corporation Main Business Overview
11.6.5 Terumo Corporation Latest Developments
11.7 ENDOLOGIX
11.7.1 ENDOLOGIX Company Information
11.7.2 ENDOLOGIX Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.7.3 ENDOLOGIX Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 ENDOLOGIX Main Business Overview
11.7.5 ENDOLOGIX Latest Developments
11.8 Cook Medical
11.8.1 Cook Medical Company Information
11.8.2 Cook Medical Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.8.3 Cook Medical Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Cook Medical Main Business Overview
11.8.5 Cook Medical Latest Developments
11.9 Bolton Medical
11.9.1 Bolton Medical Company Information
11.9.2 Bolton Medical Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.9.3 Bolton Medical Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bolton Medical Main Business Overview
11.9.5 Bolton Medical Latest Developments
11.10 Jotec GmbH
11.10.1 Jotec GmbH Company Information
11.10.2 Jotec GmbH Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.10.3 Jotec GmbH Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Jotec GmbH Main Business Overview
11.10.5 Jotec GmbH Latest Developments
11.11 Lepu
11.11.1 Lepu Company Information
11.11.2 Lepu Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.11.3 Lepu Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Lepu Main Business Overview
11.11.5 Lepu Latest Developments
11.12 Microport
11.12.1 Microport Company Information
11.12.2 Microport Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.12.3 Microport Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Microport Main Business Overview
11.12.5 Microport Latest Developments
11.13 Bioteq
11.13.1 Bioteq Company Information
11.13.2 Bioteq Interventional Cardiology and Peripheral Vascular Devices Product Offered
11.13.3 Bioteq Interventional Cardiology and Peripheral Vascular Devices Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bioteq Main Business Overview
11.13.5 Bioteq Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂